New COVID-19 Treatment Developed by Skymount Medical in Partnership With LSU Approved for Use in Patients in the United Kingdom
February 23, 2022
February 23, 2022
BATON ROUGE, Louisiana, Feb. 23 (TNSRes) -- Louisiana State University issued the following news release on Feb. 22, 2022:
Skymount Medical, a drug discovery company using an artificial intelligence, or AI, platform developed by LSU researchers to repurpose and build new drugs, announced today that it has received approval from the United Kingdom's Medicines and Healthcare products Regulatory Agency, or MHRA, to conduct a human clinical trial of its new oral therapeutic for COV . . .
Skymount Medical, a drug discovery company using an artificial intelligence, or AI, platform developed by LSU researchers to repurpose and build new drugs, announced today that it has received approval from the United Kingdom's Medicines and Healthcare products Regulatory Agency, or MHRA, to conduct a human clinical trial of its new oral therapeutic for COV . . .